SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,420 | -16.6% | 2,000 | 0.0% | 0.00% | – |
| Q2 2023 | $2,900 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2,900 | -16.2% | 2,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3,460 | -13.5% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +300.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -88.9% | 2,000 | +100.0% | 0.00% | – |
| Q1 2022 | $9,000 | -43.8% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -11.1% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | +28.6% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $14,000 | -6.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2021 | $15,000 | -21.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2020 | $19,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,376,968 | $17,639,000 | 16.57% |
| Aquilo Capital Management, LLC | 1,054,356 | $13,506,000 | 5.98% |
| VHCP Management II, LLC | 474,015 | $6,072,000 | 1.78% |
| AWM Investment Company, Inc. | 562,296 | $7,203,000 | 1.42% |
| Alphabet Inc. | 1,112,473 | $14,251,000 | 0.74% |
| BVF INC/IL | 460,706 | $5,902,000 | 0.66% |
| DAFNA Capital Management LLC | 70,000 | $897,000 | 0.39% |
| Artal Group S.A. | 600,000 | $7,686,000 | 0.31% |
| Rock Springs Capital Management LP | 525,000 | $6,725,000 | 0.26% |
| Orbimed Advisors | 507,471 | $6,501,000 | 0.10% |